Literature DB >> 11964668

Allergen-specific immunotherapy in allergic rhinitis.

H J Malling1.   

Abstract

The scope of this review is to highlight important and interesting articles in the field of allergen-specific immunotherapy in allergic rhinitis published within the past year. The review is not intended to give a full overview of published literature but rather to focus on some subjects that I find significant in relation to the understanding of the specific treatment of allergies and to the selection of different treatment modalities. The most important aspects are how to define the most suitable candidates for the specific treatment, the mechanisms of action of immunotherapy and how to optimize treatment, and finally I include some reflections on the optimal presentation of the allergen to the immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11964668     DOI: 10.1097/01.all.0000010983.53424.26

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  5 in total

1.  Specific immunotherapy-induced Sjögren's syndrome.

Authors:  N Turkcapar; G Kinikli; S Dizbay Sak; M Duman
Journal:  Rheumatol Int       Date:  2005-06-17       Impact factor: 2.631

Review 2.  Allergen injection immunotherapy for seasonal allergic rhinitis.

Authors:  M A Calderon; B Alves; M Jacobson; B Hurwitz; A Sheikh; S Durham
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 3.  Allergic rhinitis in children : diagnosis and management strategies.

Authors:  William E Berger
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  Update on allergy immunotherapy.

Authors:  William Davidson; Sean Lucas; Larry Borish
Journal:  Allergy Asthma Clin Immunol       Date:  2005-12-15       Impact factor: 3.406

5.  Long-term Effects of Specific Allergen Immunotherapy Against House Dust Mites in Polysensitized Patients With Allergic Rhinitis.

Authors:  Sang Hoon Kim; Seung Youp Shin; Kun Hee Lee; Sung Wan Kim; Joong Saeng Cho
Journal:  Allergy Asthma Immunol Res       Date:  2014-05-27       Impact factor: 5.764

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.